Dual GLP-1 / GIP
Tirzepatide. Two pathways, one shot.
A once-weekly dual GLP-1 and GIP receptor agonist, compounded and prescribed to work on two metabolic pathways at once for the right candidate.
Find your protocol
A once-weekly dual GLP-1 and GIP receptor agonist, compounded and prescribed to work on two metabolic pathways at once for the right candidate.
Find your protocolTirzepatide engages both GLP-1 and GIP receptors, which can mean stronger appetite control for some patients. Your provider determines whether it is appropriate and titrates carefully.
Every protocol is provider-directed and requires a prescription. No algorithms, no offshore prescribers.
Board-certified, US-licensed physicians review every intake and approve your protocol.
Compounded and dispensed by US-licensed 503A/503B pharmacies, third-party tested for purity.
LegitScript-certified and HIPAA-compliant. Your care held to the standard real medicine demands.
Transparent pricing up front, member discounts on every refill, and a free $499 Mission Provisions Kit. Your dose can go up. Your price won't.
Become a memberThat's a clinical decision your provider makes based on your goals, history, and response.
Results vary. Your provider sets realistic expectations and adjusts your plan as you go.
Yes. Board-certified, US-licensed physicians review every intake and determine what is clinically appropriate. Not everyone qualifies for every program.
Compounded medications and peptides are prepared by US-licensed 503A/503B pharmacies and third-party tested for purity. They are not FDA-approved.